Shanghai, China

Zhaoyu Wu

This inventor holds 2 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent. Top assignee: Onquality Pharmaceuticals China Ltd.. Active years: 2020-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhaoyu Wu. Retrieved from https://idiyas.com/inventor/zhaoyu-wu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 7.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Zhaoyu Wu: Innovator in Tumor Therapy

Introduction

Zhaoyu Wu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medicine, particularly in the development of innovative therapies for cancer treatment. With a focus on nitric oxide releasing agents, his work aims to improve patient outcomes in tumor therapy.

Latest Patents

Zhaoyu Wu holds 2 patents that showcase his innovative approaches. His first patent is titled "Method of preventing or treating side effect of tumor therapy." This application relates to the use of a nitric oxide releasing agent in the preparation of a medicament for preventing or treating diseases or disorders associated with the administration of a VEGFR inhibitor and/or VEGF inhibitor. The method involves administering a prophylactically or therapeutically effective amount of the nitric oxide releasing agent to a subject in need.

His second patent is "Method for preventing or treating diseases associated with the inhibition of EGFR." This application provides a use of a nitric oxide releasing agent in preparing a medicament for preventing or treating EGFR inhibition associated epithelial diseases in a subject. It also includes a pharmaceutical composition or a kit comprising an EGFR inhibitor and a nitric oxide releasing agent.

Career Highlights

Zhaoyu Wu is currently associated with Onquality Pharmaceuticals China Ltd., where he continues to advance his research and development efforts. His work is pivotal in addressing the challenges faced in cancer therapies, particularly in mitigating side effects associated with existing treatments.

Collaborations

Zhaoyu collaborates with notable colleagues, including Shiyi Zhang and Chao Liu. Their combined expertise contributes to the innovative projects at Onquality Pharmaceuticals.

Conclusion

Zhaoyu Wu's contributions to the field of tumor therapy through his innovative patents highlight his commitment to improving cancer treatment. His work not only addresses critical medical challenges but also paves the way for future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…